Insider Trading Activity G1 Therapeutics Inc (NASDAQ:GTHX) – VP Sold 750 shares of Stock

ME Staff
-
0

Insider Trading Activity For G1 Therapeutics Inc (NASDAQ:GTHX)

Jennifer K Moses , VP of G1 Therapeutics Inc (NASDAQ:GTHX) reportedly Sold 750 shares of the company’s stock at an average price of 19.96 for a total transaction amount of $14,970.00 SEC Form

Insider Trading History For G1 Therapeutics Inc (NASDAQ:GTHX)

  • On 5/22/2017 Ra Capital Healthcare Fund Lp, Insider, bought 400,000 with an average share price of $15.00 per share and the total transaction amounting to $6,000,000.00.View SEC Filing
  • On 5/22/2017 Fredric N Eshelman, Director, bought 300,000 with an average share price of $15.00 per share and the total transaction amounting to $4,500,000.00.View SEC Filing
  • On 5/22/2017 Clay Thorp, Major Shareholder, bought 133,333 with an average share price of $15.00 per share and the total transaction amounting to $1,999,995.00.View SEC Filing
  • On 11/13/2017 Fredric N Eshelman, Director, bought 250,000 with an average share price of $19.73 per share and the total transaction amounting to $4,932,500.00.View SEC Filing
  • On 11/20/2017 Medimmune Ventures, Inc., Major Shareholder, sold 200,000 with an average share price of $20.01 per share and the total transaction amounting to $4,002,000.00.View SEC Filing
  • On 12/1/2017 Medimmune Ventures, Inc., Major Shareholder, sold 133,906 with an average share price of $19.75 per share and the total transaction amounting to $2,644,643.50.View SEC Filing
  • On 12/15/2017 Medimmune Ventures, Inc., Major Shareholder, sold 200,000 with an average share price of $19.75 per share and the total transaction amounting to $3,950,000.00.View SEC Filing

    • Analyst Ratings History For G1 Therapeutics Inc (NASDAQ:GTHX)

    • On 6/12/2017 JPMorgan Chase & Co. Initiated Coverage of rating Overweight to Overweight with a price target of $23.00
    • On 6/12/2017 Needham & Company LLC Initiated Coverage of rating Buy to Buy with a price target of $34.00
    • On 6/12/2017 Wedbush Initiated Coverage of rating Outperform with a price target of $31.00
    • On 11/8/2017 Cowen Reiterated Rating Buy
    • On 12/19/2017 BTIG Research Initiated Coverage of rating Buy with a price target of $38.00

    Recent Trading Activity for G1 Therapeutics Inc (NASDAQ:GTHX)
    Shares of G1 Therapeutics Inc closed the previous trading session at 19.00 down -0.16 0.84% with 19.190000534057617 shares trading hands.